8-K/A

FORM 8-K/A

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: November 16, 2011
Period of Report: August 22, 2011
Accession Number: 0001144204-11-065345

View Document ↗ View on SEC.gov ↗